Medicinova Inc. Stock
Price
Target price
-
-
-
-
-
?7.67
WKN: A0LF3U / Symbol: MNOV / Name: MediciNova Inc / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Medicinova Inc. Stock
Medicinova Inc. is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
With a target price of 7 € there is potential for a 117.53% increase which would mean more than doubling the current price of 3.22 € for Medicinova Inc..
Pros and Cons of Medicinova Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicinova Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 4.690% | 16.638% | 41.470% | -49.754% | -8.438% | -52.778% | -92.985% |
| Evolus Inc | 2.510% | -6.031% | 23.198% | -57.192% | -22.239% | -41.945% | -42.340% |
| Sangamo Therapeutics Inc. | -10.030% | -53.171% | -61.677% | -85.041% | -70.869% | -92.335% | -98.960% |
Comments
MediciNova (MNOV) had its "buy" rating reaffirmed by Maxim Group. They now have a $6.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (MNOV) is now covered by HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat